Amy E. Bland, MD

Publications

1. French AE, Gregg V, Newberry Y, Parsons T. Umbilical cord stricture: a cause of recurrent fetal death. Am J Obstet Gynecol. 2005; 105(5 Pt 2): 1235-1239.
2. Everett E, Heuser C, French AE, Pastore L, Rice L, Taylor P, Irvin W. Predictors of suboptimal surgical cytoreduction in women treated with initial cytoreductive surgery for advanced stage epithelial ovarian cancer. Am J Obstet Gynecol. 2005; 193(2): 568-574.
3. Everett E, French AE, Stone R, Pastore L, Jazaeri A, Andersen W, Taylor P. Initial chemotherapy followed by surgical cytoreduction for the treatment of stage III/IV epithelial ovarian cancer. Am J Obstet Gynecol. 2006; 195(2): 568-574.
4. Alvarez Secord A, Havrilesky L, Bae-JumpV, Chin J, Calingaert B, Bland AE, Rutledge T, Berchuck A, Clarke-Pearson D, Valea F, Gehrig P. The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer. Gynecol Oncol. 2007; 107(2): 285-291.
5. Bland AE, Everett E, Pastore L, Andersen W, Taylor P. Predictors of suboptimal surgical cytoreduction in women with advanced epithelial ovarian cancer treated with initial chemotherapy. Int J Gynecol Cancer. 2008; 18(4): 629-636.
6. Bland AE, Shah A, Piscitelli J, Bentley R, Secord A. Desmoplastic small round cell tumor masquerading as ovarian cancer. Int J Gynecol Cancer. 2008; 18(4): 847-50.
7. Schildkraut JM, Moorman PG, Bland AE, Halabi S, Calingaert B, Whitaker R, Lee PS, Elkins-Williams T, Bentley RC, Marks JR, Berchuck A. Cyclin E overexpression in epithelial ovarian cancer characterizes an etiologic subgroup. Cancer Epidemiol Biomarkers Prev. 2008; 17(3): 585-593.
8. Bland AE, Calingaert B, Lee PS, Valea FA, Secord AA, Berchuck A, Soper JT, Havrilesky L. Relationship between tamoxifen use and high risk endometrial cancer histologic types. Gynecol Oncol. 2009; 112(1): 150-4.
9. Bland AE, Stone R, Heuser C, Jazaeri A, Shutter J, Atkins K, Rice L. A Clinical and Biological Comparison between Malignant Mixed Müllerian Tumors and Grade 3 Endometriod Endometrial Carcinomas. Int J Gynecol Cancer. 2009;19(2):261-5.
10. Neubauer NL, Havrilesky LJ, Calingaert B, Bernardini MQ, Fleming ND, Bland AE, Secord AA. The role of lymphadenectomy in the management of preoperative grade 1 endometrial carcinoma. Gynecol Oncol. 2009;112(3):511-6..
11. Bernardini MQ, May T, Khalifa M, Bland AE, Nofech-Mozes S, Berchuck A, Covens A, Havrilesky L. Evaluation of two management strategies for preoperative grade 1 endometrial cancer. Manuscript accepted, Obstet Gynecol.

Presentations

1. French A, Everett E, Heuser C, Pastore L, Stone R, Andersen W, Taylor P, Rice L, Irvin W. Initial Chemotherapy for the treatment of advanced stage epithelial ovarian cancer patients and predictors of suboptimal surgical cytoreduction. Oral presentation at the Mid-Atlantic Gynecologic Oncology Society, October 2004. Poster presentation at the Society of Gynecologic Oncology, March 2005.
2. Schildkraut J, French A, Lee PS, Elkins-Williams T, Calingaert B, Bentley R, Murphy S, Marks J, Berchuck A. Molecular epidemiology of cyclin E overexpression in epithelial ovarian cancer. Poster presentation at the Society of Gynecologic Oncology Meeting, March 2006.
3. Bland A, Stone R, Heuser C, Jazaeri A, Shutter J, Atkins K, Rice L. A Clinical and Biological Comparison between Malignant Mixed Müllerian Tumors and Grade 3 Endometriod Endometrial Carcinomas. Oral presentation at the Mid-Atlantic Gynecologic Oncology Society, October 2006. Poster presentation at the Society of Gynecologic Oncology Meeting, March 2007.
4. Bland A, Berchuck A, Murphy S. Concordance of methylation status of RASSF1 in matched ovarian tumor and serum specimens using a novel real time PCR assay.Poster presentation at the Society of Gynecologic Oncology Meeting, March 2007.
5. Bland A, Matsumura N, Furey T, Goh L, Bernardini M, Perry T, Fujii S, Berchuck A, Murphy S. Convergent Analyses Reveal Regional Epigenetic and Genetic Changes at Chromosome 3p21.31 in Serous Epithelial Ovarian Cancer and Support a Tumor Suppressive Function for RASSF1.Poster presentation at the Society of Gynecologic Oncology Meeting, March 2007.
6. Lee P, Bland A, Valea F, Havrilesky L, Berchuck A, Alvarez Secord A. Robotic assisted Laparoscopic Gynecologic Procedures in a Fellowship Training Program. Poster presentation at the Society of Gynecologic Oncology Meeting, March 2007.
7. Alvarez Secord A, Havrilesky L, Bae-JumpV, Chin J, Calingaert B, Bland A, Rutledge T, Berchuck A, Clarke-Pearson D, Valea F, Gehrig P. The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer. Oral presentation at the Society of Gynecologic Oncology meeting, March 2007.
8. Duke University, Department of Obstetrics and Gynecology, Grand Rounds, April 2008. A Different Perspective: the Vegetarian Diet.
9. Secord AA, Neubauer NL, Havrilesky LJ, Calingaert B, Bernardini MQ, Bland AE, Fleming ND. The role of lymphadenectomy in the management of preoperative grade 1 endometrial carcinoma. Poster presentation at the Society of Gynecologic Oncology Meeting, March 2009.
10. Havrilesky LJ, Fleming ND, Valea F, Allen TK, Broadwater G, Bland AE, Habib A. Minimally invasive staging for endometrial cancer is associated with lower pain, nausea, and narcotic use. Poster presentation at the Society of Gynecologic Oncology Meeting, March 2009.